304 related articles for article (PubMed ID: 29938832)
1. Assessment of Bayesian expected power via Bayesian bootstrap.
Liu F
Stat Med; 2018 Oct; 37(24):3471-3485. PubMed ID: 29938832
[TBL] [Abstract][Full Text] [Related]
2. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
Doi M; Takahashi F; Kawasaki Y
Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
[TBL] [Abstract][Full Text] [Related]
3. Bayesian approach to non-inferiority trials for normal means.
Gamalo MA; Wu R; Tiwari RC
Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
[TBL] [Abstract][Full Text] [Related]
4. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD
Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
[TBL] [Abstract][Full Text] [Related]
5. A comparison of Bayesian and Monte Carlo sensitivity analysis for unmeasured confounding.
McCandless LC; Gustafson P
Stat Med; 2017 Aug; 36(18):2887-2901. PubMed ID: 28386994
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian approach on sample size calculation for comparing means.
Wang H; Chow SC; Chen M
J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian Power Analysis Procedure Considering Uncertainty in Effect Size Estimates from a Meta-analysis.
Du H; Wang L
Multivariate Behav Res; 2016; 51(5):589-605. PubMed ID: 27485763
[TBL] [Abstract][Full Text] [Related]
8. An extension of Bayesian expected power and its application in decision making.
Liu F
J Biopharm Stat; 2010 Sep; 20(5):941-53. PubMed ID: 20721783
[TBL] [Abstract][Full Text] [Related]
9. Efficient computation of partial expected value of sample information using Bayesian approximation.
Brennan A; Kharroubi SA
J Health Econ; 2007 Jan; 26(1):122-48. PubMed ID: 16945438
[TBL] [Abstract][Full Text] [Related]
10. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
11. Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter.
Waleed M; He J; Phadnis MA
J Biopharm Stat; 2024 Jul; 34(4):469-487. PubMed ID: 37545144
[TBL] [Abstract][Full Text] [Related]
12. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
Park ES; Symanski E; Han D; Spiegelman C
Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
[TBL] [Abstract][Full Text] [Related]
13. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
14. Empirical Bayes models of Poisson clinical trials and sample size determination.
Zaslavsky BG
Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
[TBL] [Abstract][Full Text] [Related]
15. Joining forces of Bayesian and frequentist methodology: a study for inference in the presence of non-identifiability.
Raue A; Kreutz C; Theis FJ; Timmer J
Philos Trans A Math Phys Eng Sci; 2013 Feb; 371(1984):20110544. PubMed ID: 23277602
[TBL] [Abstract][Full Text] [Related]
16. Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD; Makuch RW; Peduzzi PN
Contemp Clin Trials; 2015 Mar; 41():160-71. PubMed ID: 25583273
[TBL] [Abstract][Full Text] [Related]
17. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
18. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD; Peduzzi PN
Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
[TBL] [Abstract][Full Text] [Related]
19. Bayesian estimation of the proportion of treatment effect captured by a surrogate marker.
Cowles MK
Stat Med; 2002 Mar; 21(6):811-34. PubMed ID: 11870819
[TBL] [Abstract][Full Text] [Related]
20. Bayesian methods for pilot studies.
Willan AR; Thabane L
Clin Trials; 2020 Aug; 17(4):414-419. PubMed ID: 32297539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
